Delivery Order SPE2DP22D0009-SPE2DP23F5834

Award Date 8/29/23

Potential Completion Date 3/18/24

Potential Value $39K

Federal Agency

Medical Supply Chain

Awardee

Glaxosmithkline, LLC FRHTPHMZMX47

Ultimate Awardee

Not listed

NAICS Category

325412 - Pharmaceutical Preparation Manufacturing

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Not Competed

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Durham, NC 27701, USA

Solicitation Procedures

Only One Source

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, for the supply of the antiviral medication zanamivir. The firm fixed price contract has a potential value of $39,375.00 and a completion date of March 18, 2024. The contract is not associated with a set-aside designation. Glaxosmithkline has been awarded multiple federal contracts and indefinite delivery vehicles to provide vaccines, antiviral medications, and other pharmaceutical products to government agencies such as the Departments of Defense, Veterans Affairs, and Health and Human Services to support disease prevention, immunization, and drug stockpiling initiatives.

Generated 4/21/24, 9:13 AM